IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") today announced that it has appointed Terry Lierman as an independent director to its board of directors.
Mr. Lierman is currently Co-Chair of the Board of Advisors at the Institute of Human.
Promising Results: TGR-63 Enhances Memory in Alzheimer s Mouse Model streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
IGC Pharma, Inc. today announced the results of preclinical studies investigating its drug candidate TGR-63 as a treatment for Alzheimer s disease. The data demonstrated enhanced memory function in.
By Sabela Ojea IGC Pharma said its Alzheimer's disease drug candidate TGR-63 demonstrated enhanced memory function in preclinical studies. The pharmaceutical.